Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer.
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
EGFR-mutated Lung Cancer in Randomized Investigator-Initiated Study
- Status
- RECRUITING
- Phase
- PHASE3
Efficacy and Safety of Almonertinib Combined With Stereotactic Body Radiotherapy (SBRT) in the Treatment of Non-small Cell Lung Cancer With EGFR Sensitive Mutation: a Single-arm, Open-label Clinical Trial
- Status
- RECRUITING
- Phase
- NA
ETERNALS: Remote Monitoring in Lung Cancer Patients
- Status
- NOT_YET_RECRUITING
- Phase
- NA
The Recurrence Gene Profiles of Adjuvant Osimertinib Therapy in Resected Non-Small-Cell Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate 14C-bemcentinib in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Prospective, Open-label, Single-center, Single-arm Phase II Clinical Study of Cadonilimab (AK104) Combined With Monotherapy Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer With Negative Driver Genes and Failed Immunotherapy
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced
- Status
- RECRUITING
- Phase
- N/A
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
- Status
- RECRUITING
- Phase
- PHASE2
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Acupuncture for Enhancing Immunotherapy in Advanced NSCLC：a Pilot Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
TIL Therapy in Non-small-cell Lung Cancer (NSCLC) Patients
- Status
- RECRUITING
- Phase
- PHASE2
Gumarontinib Combined With 3rd EGFR-TKI in Patients With Non-small Cell Lung Cancer.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Volrustomig Priming Regimens Exploratory Phase II Platform Study
- Status
- RECRUITING
- Phase
- PHASE2
EXL01 in Combination With Nivolumab for Advanced NSCLC Refractory to Immunotherapy.
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination
- Status
- TERMINATED
- Phase
- PHASE1
A Study of SKB264 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3